MCRB

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

Seres Therapeutics reported early clinical data supporting the potential of SER-155 in immune checkpoint inhibitor-related enterocolitisJul 8, 2026
Seres Therapeutics announces further constructive feedback from FDA on SER-155 Phase 2 study protocol and implements cost reduction actions to extend cash runwaySep 23, 2025